Free Trial

Ardent Health Partners (ARDT) Stock Price, News & Analysis

Ardent Health Partners logo
$12.92 -0.83 (-6.04%)
Closing price 03:58 PM Eastern
Extended Trading
$12.90 -0.02 (-0.15%)
As of 04:44 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Ardent Health Partners Stock (NYSE:ARDT)

Key Stats

Today's Range
$12.39
$13.41
50-Day Range
$13.09
$15.31
52-Week Range
$12.39
$20.72
Volume
621,206 shs
Average Volume
407,208 shs
Market Capitalization
$1.84 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$21.18
Consensus Rating
Buy

Company Overview

Ardent Health Partners, Inc. owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee. Ardent Health Partners, Inc. is a subsidiary of EGI-AM Investments, L.L.C.

Remove Ads
Receive ARDT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ardent Health Partners and its competitors with MarketBeat's FREE daily newsletter.

ARDT Stock News Headlines

Ardent Health Names Dave Caspers as Operating Chief
Now I look stupid. Real stupid...
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.
Ardent Health Partners, Inc. (ARDT) Receives a Hold from J.P. Morgan
See More Headlines

ARDT Stock Analysis - Frequently Asked Questions

Ardent Health Partners' stock was trading at $17.08 at the start of the year. Since then, ARDT shares have decreased by 24.4% and is now trading at $12.92.
View the best growth stocks for 2025 here
.

Ardent Health Partners, LLC (NYSE:ARDT) announced its quarterly earnings data on Wednesday, February, 26th. The company reported $0.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.50 by $0.31. The firm earned $1.61 billion during the quarter, compared to analysts' expectations of $1.48 billion.

Ardent Health Partners (ARDT) raised $192 million in an IPO on Thursday, July 18th 2024. The company issued 12,000,000 shares at $16.00 per share.

Shares of ARDT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Ardent Health Partners investors own include Broadcom (AVGO), 4D Molecular Therapeutics (FDMT), Mirum Pharmaceuticals (MIRM), Micron Technology (MU), Uber Technologies (UBER), Advanced Micro Devices (AMD) and ASML (ASML).

Company Calendar

Last Earnings
2/26/2025
Today
4/01/2025
Next Earnings (Estimated)
5/28/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
General medical & surgical hospitals
Sub-Industry
Healthcare
Current Symbol
NYSE:ARDT
Previous Symbol
NYSE:ARDT
Web
N/A
Fax
N/A
Employees
24,200
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$21.18
High Stock Price Target
$25.00
Low Stock Price Target
$18.00
Potential Upside/Downside
+63.4%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
12 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$5.97 billion
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$1.85 billion
Optionable
Optionable
Beta
N/A
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (NYSE:ARDT) was last updated on 4/1/2025 by MarketBeat.com Staff
From Our Partners